Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Cintas

Dow Jones Soars Amid Strong Arm IPO Gains; Cathie Wood Loads Up On This Stock After 43% Plunge

The Dow Jones rallied as stocks popped on retail data. Arm stock rocketed on its IPO. Cathie Wood loaded up on a beaten down tech stock.

Investors Business Daily

Cintas Stock No. 1 In Its Industry; Gets Rating Upgrade

Cintas stock shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 79 to 84.

Investors Business Daily

Cintas Stock Thrives; Market Leadership Expands Beyond Big Tech

Cintas stock Relative Strength Rating enters the 80-plus level.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Price Hikes Don't Necessarily Translate to Higher Profits

Many big U.S. businesses say they have been able to increase prices this year with limited pushback from customers. Not all the changes are leading to higher corporate profits.

Bangkok Post

Dow Jones Rises Ahead Of Powell Speech; 10-Year Treasury Yield Briefly Tops 4%

The Dow Jones Industrial Average rose Wednesday, ahead of Fed chief Powell's speech, struggling to avoid a seventh straight decline.

Investors Business Daily

Cintas Stock: CTAS Beats Q4 Earnings Estimates, Sees Record FY Revenue

CTAS will announce fourth-quarter earnings Thursday as it looks to close the 2022 fiscal year with strong growth numbers.

Investors Business Daily

Analyzing Cintas's Short Interest

Cintas's (NASDAQ:CTAS) short percent of float has risen 7.2% since its last report. The company recently reported that it has 1.17 million shares sold short, which is 1.34% of all regular shares that are available for trading.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

$1000 Invested In This Stock 10 Years Ago Would Be Worth $9,700 Today

Cintas (NASDAQ:CTAS) has outperformed the market over the past 10 years by 14.47% on an annualized basis producing an average annual return of 25.43%. Currently, Cintas has a market capitalization of $38.87 billion.

Benzinga

Analyzing Cintas's Short Interest

Cintas's (NASDAQ:CTAS) short percent of float has risen 5.66% since its last report. The company recently reported that it has 975.10 thousand shares sold short, which is 1.12% of all regular shares that are available for trading.

Benzinga

$100 Invested In Cintas 15 Years Ago Would Be Worth This Much Today

Cintas (NASDAQ:CTAS) has outperformed the market over the past 15 years by 9.68% on an annualized basis producing an average annual return of 16.14%. Currently, Cintas has a market capitalization of $38.79 billion.

Benzinga

$1000 Invested In Cintas 5 Years Ago Would Be Worth This Much

Cintas (NASDAQ:CTAS) has outperformed the market over the past 5 years by 14.57% on an annualized basis producing an average annual return of 25.74%. Currently, Cintas has a market capitalization of $40.73 billion.

Benzinga

5 Safe-Haven Dividend Stocks to Add to Your Portfolio

Deepening logistical disruptions caused by the Russia-Ukraine war, record-high inflation, and high oil prices have dampened investor sentiment. Furthermore, many economists expect the economy to succumb to a recession, with inflation hitting a fresh 40-year high and oil prices soaring. Therefore, we think it could be wise to bet on…

StockNews.com

Benzinga's Top Ratings Upgrades, Downgrades For March 30, 2022

Upgrades

Benzinga

Read How Analysts Reacted To Cintas's Q3 Results

Cintas Corp's (NASDAQ:CTAS) price target was raised to $493 from $460 by Goldman Sachs analyst George Tong while maintaining the Buy rating on the shares. Tong predicts continued strength from the healthcare sector that is increasingly adopting uniform rental programs at Cintas post-COVID due to cost and hygiene benefits. Related: Cintas' Q3 Results Beat Estimates, Clocks…

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Cintas Flashes Strength Amid Market Transition

Cintas shows rising price performance, earning an upgrade to its IBD Relative Strength Rating

Benzinga

Cintas' Q3 Results Beat Estimates, Clocks 10% Revenue Growth

Cintas Corp (NASDAQ:CTAS) reported third-quarter revenue growth of 10.3% year-over-year to $1.96 billion and +10% on an organic basis, beating the consensus of $1.91 billion. Adjusted EPS was $2.69 for the quarter, which beat the consensus of $2.43. The operating income increased 24.9% Y/Y to $407.61 million, and the margin expanded by 242…

Benzinga

Recap: Cintas Q3 Earnings

Cintas (NASDAQ:CTAS) reported its Q3 earnings results on Wednesday, March 23, 2022 at 08:30 AM. Here's what investors need to know about the announcement.

Benzinga

Cintas's Earnings Outlook

Cintas (NASDAQ:CTAS) is set to give its latest quarterly earnings report on Wednesday, 2022-03-23. Here's what investors need to know before the announcement. Analysts estimate that Cintas will report an earnings per share (EPS) of $2.43.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Cintas's Earnings: A Preview

Benzinga

Cintas Q3 2022 Earnings Conference Call On March 23, 2022 At 10:00 AM ET

Cintas (NASDAQ:CTAS) will host a conference call at 10:00 AM ET on March 23, 2022, to discuss Q3 2022 earnings results. How to Attend Cintas (CTAS) Conference Call Follow this link to access the live webcast.

Benzinga

Death Cross Looms Over Cintas Investors

If history is any guide, there may be trouble ahead for shares of Cintas (NASDAQ:CTAS). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

1 2 3

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.